(2) | The amounts shown in this column in respect of 2021, 2020 and 2019 represent the grant date fair value, as determined in accordance with ASC 718, of time-based RSUs awarded on February 25, 2021, February 26, 2020, and March 15, 2019 in the amounts of: 12,319, 16,071, and 22,195, for Mr. Spector; 6,796, 8,207, and 11,097, for Mr. Jones; 3,908, 6,423, and 8,998 for Mr. Fartaj; 4,927, 6,423, and 8,909 for Mr. Chang, respectively; and 2,973 for Mr. Perotti on February 25, 2021. Also includes the grant date fair value, as determined in accordance with ASC 718, of the (a) performance-based RSUs awarded on February 25, 2021, February 26, 2020, and March 15, 2019 in the amounts of 30,798, 32,143, and 44,390 for Mr. Spector; 16,992, 16,414, and 22,195 for Mr. Jones; 9,770, 12,846, and 17,997 for Mr. Fartaj; 12,319, 12,846, and 17,819 for Mr. Chang; and 7,434 for Mr. Perotti, respectively, pursuant to our 2013 Plan. See “—2021 Outstanding Equity Awards at Fiscal Year-End” below. Such aggregate grant date fair values do not take into account any estimated forfeitures related to service vesting conditions. For more information on the assumptions used in our estimates of value, please refer to Note 20—Stock-based Compensation in our Annual Report on Form 10-K filed on February 23, 2022. The value of the performance-based RSUs awarded on February 25, 2021, February 26, 2020, and March 15, 2019, assuming that the highest level of performance conditions will be achieved and based on a grant date fair value per share of $58.85, $35.03, and $22.92, is $3,398,352, $2,111,188, and $1,322,644 for Mr. Spector; $1,874,961, $1,078,083, and $661,311 for Mr. Jones; $1,078,014, $843,733, and $536,236 for Mr. Fartaj, and $1,359,317, $843,733, and $530,919 for Mr. Chang; and $820,251 for Mr. Perotti, respectively. The amounts reported in this column reflect the accounting cost for these RSUs and do not correspond to the actual economic value that may be received by upon vesting and/or settlement of the RSUs. |